Your browser doesn't support javascript.
loading
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study.
Sousa-Pinto, Bernardo; Schünemann, Holger J; Sá-Sousa, Ana; Vieira, Rafael José; Amaral, Rita; Anto, Josep M; Klimek, Ludger; Czarlewski, Wienczyslawa; Mullol, Joaquim; Pfaar, Oliver; Bedbrook, Anna; Brussino, Luisa; Kvedariene, Violeta; Larenas-Linnemann, Désirée E; Okamoto, Yoshitaka; Ventura, Maria Teresa; Agache, Ioana; Ansotegui, Ignacio J; Bergmann, Karl C; Bosnic-Anticevich, Sinthia; Canonica, G Walter; Cardona, Victoria; Carreiro-Martins, Pedro; Casale, Thomas; Cecchi, Lorenzo; Chivato, Tomas; Chu, Derek K; Cingi, Cemal; Costa, Elísio M; Cruz, Alvaro A; Del Giacco, Stefano; Devillier, Philippe; Eklund, Patrik; Fokkens, Wytske J; Gemicioglu, Bilun; Haahtela, Tari; Ivancevich, Juan Carlos; Ispayeva, Zhanat; Jutel, Marek; Kuna, Piotr; Kaidashev, Igor; Khaitov, Musa; Kraxner, Helga; Laune, Daniel; Lipworth, Brian; Louis, Renaud; Makris, Michael; Monti, Riccardo; Morais-Almeida, Mario; Mösges, Ralph.
Afiliação
  • Sousa-Pinto B; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Schünemann HJ; CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, Portugal.
  • Sá-Sousa A; RISE - Health Research Network, University of Porto, Porto, Portugal.
  • Vieira RJ; Department of Health Research Methods, Evidence, and Impact & Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Amaral R; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Anto JM; CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, Portugal.
  • Klimek L; RISE - Health Research Network, University of Porto, Porto, Portugal.
  • Czarlewski W; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Mullol J; CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, Portugal.
  • Pfaar O; RISE - Health Research Network, University of Porto, Porto, Portugal.
  • Bedbrook A; MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Brussino L; CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, Portugal.
  • Kvedariene V; RISE - Health Research Network, University of Porto, Porto, Portugal.
  • Larenas-Linnemann DE; ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.
  • Okamoto Y; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Ventura MT; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Agache I; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Ansotegui IJ; Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany.
  • Bergmann KC; Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Bosnic-Anticevich S; Medical Consulting Czarlewski, Levallois, France.
  • Canonica GW; Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
  • Cardona V; Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Carreiro-Martins P; ARIA, Montpellier, France.
  • Casale T; Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital, Torino, Italy.
  • Cecchi L; Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Chivato T; Institute of Clinical medicine, Clinic of Chest diseases and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Chu DK; Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
  • Cingi C; Chiba University Hospital and Chiba Rosai Hospital, Chiba, Japan.
  • Costa EM; Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
  • Cruz AA; Transylvania University Brasov, Brasov, Romania.
  • Del Giacco S; Department of Allergy and Immunology, Hospital Quironsalud Bizkaia, Bilbao, Spain.
  • Devillier P; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Eklund P; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
  • Fokkens WJ; Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney and Sydney Local Health District, Sydney, New South Wales, Australia.
  • Gemicioglu B; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Haahtela T; Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.
  • Ivancevich JC; Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron & ARADyAL research network, Barcelona, Spain.
  • Ispayeva Z; Serviço de Imunoalergologia, Hospital de Dona Estefânia, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Jutel M; NOVA Medical School/Comprehensive Health Research Centre (CHRC), Lisbon, Portugal.
  • Kuna P; Division of Allergy/immunology, University of South Florida, Tampa, Florida, USA.
  • Kaidashev I; SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
  • Khaitov M; School of Medicine, University CEU San Pablo, Madrid, Spain.
  • Kraxner H; Department of Health Research Methods, Evidence, and Impact & Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Laune D; ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Lipworth B; UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal.
  • Louis R; Fundaçao ProAR, Federal University of Bahia and GARD/WHO Planning Group, Salvador, Brazil.
  • Makris M; Department of Medical Sciences and Public Health and Unit of Allergy and Clinical Immunology, University Hospital "Duilio Casula", University of Cagliari, Cagliari, Italy.
  • Monti R; VIM Suresnes, UMR 0892, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
  • Morais-Almeida M; Department of Computing Science, Umeå University, Umeå, Sweden.
  • Mösges R; Department of Otorhinolaryngology, Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands.
Allergy ; 78(4): 968-983, 2023 04.
Article em En | MEDLINE | ID: mdl-36325824
ABSTRACT

INTRODUCTION:

Data from mHealth apps can provide valuable information on rhinitis control and treatment patterns. However, in MASK-air®, these data have only been analyzed cross-sectionally, without considering the changes of symptoms over time. We analyzed data from MASK-air® longitudinally, clustering weeks according to reported rhinitis symptoms.

METHODS:

We analyzed MASK-air® data, assessing the weeks for which patients had answered a rhinitis daily questionnaire on all 7 days. We firstly used k-means clustering algorithms for longitudinal data to define clusters of weeks according to the trajectories of reported daily rhinitis symptoms. Clustering was applied separately for weeks when medication was reported or not. We compared obtained clusters on symptoms and rhinitis medication patterns. We then used the latent class mixture model to assess the robustness of results.

RESULTS:

We analyzed 113,239 days (16,177 complete weeks) from 2590 patients (mean age ± SD = 39.1 ± 13.7 years). The first clustering algorithm identified ten clusters among weeks with medication use seven with low variability in rhinitis control during the week and three with highly-variable control. Clusters with poorly-controlled rhinitis displayed a higher frequency of rhinitis co-medication, a more frequent change of medication schemes and more pronounced seasonal patterns. Six clusters were identified in weeks when no rhinitis medication was used, displaying similar control patterns. The second clustering method provided similar results. Moreover, patients displayed consistent levels of rhinitis control, reporting several weeks with similar levels of control.

CONCLUSIONS:

We identified 16 patterns of weekly rhinitis control. Co-medication and medication change schemes were common in uncontrolled weeks, reinforcing the hypothesis that patients treat themselves according to their symptoms.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rinite / Telemedicina Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Portugal

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rinite / Telemedicina Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Portugal